The inability to dismantle the Vice Clause, which has plagued the SexTech sector since it was formed in the mid-2010s, is a tale as old as the time of an evolving cycle of wealth and the proliferation of consumerism. But now we have a multi-trillion dollar industry behind what we now know as Sexual Health & Technology, the IP branch of what is the oldest industry in the world, the sex industry. As we near a decade of SexTech, we have multiple billion-dollar categories known as FemTech, Menopause, Erectile Dysfunction, and more. In short, it’s either been family planning or porn and everything in between.

In 2016, the terms Femtech and SexTech were coined, and these sectors, largely driven by women, have been on the rise since. However, as sexual health was considered vice until 2019, innovations in this space saw minimal investment until the rise of COVID-19 saw a steep rise in consumer demand and sales.

Now the Sexual Health & Technology industry is estimated to reach $37.2 billion dollars by 2023 and women’s health is projected to be a trillion-dollar industry by 2027. In her keynote, Dominnique Karetsos will discuss how the Vice Clause has impacted investment and what considerations investors need to know when following the future consumer and global supply.